Spanker Biotech Profile
Key Indicators
- Authorised Capital ₹ 9.10 M
as on 28-12-2024
- Paid Up Capital ₹ 9.10 M
as on 28-12-2024
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.02 Cr
as on 28-12-2024
- Satisfied Charges ₹ 3.00 M
as on 28-12-2024
About Spanker Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.10 M and a paid-up capital of Rs 9.10 M.
The company currently has active open charges totaling ₹3.02 Cr. The company has closed loans amounting to ₹3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Munish Salwan, Amarjit Salwan, and Mithun Salwan serve as directors at the Company.
- CIN/LLPIN
U24230HP2006PLC029629
- Company No.
029629
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- LocationH P, Himachal Pradesh
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Spanker Biotech Limited offer?
Spanker Biotech Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Digestive System Drugs & Medicines, Antacid Drugs, Nutraceuticals & Dietary Supplements, Mineral Supplement, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Ayurvedic Powder and Medicinal Herbs, Herbal Powder.
Who are the key members and board of directors at Spanker Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Munish Salwan  | Director | 02-Feb-2006 | Current |
| Amarjit Salwan | Director | 02-Feb-2006 | Current |
| Mithun Salwan | Director | 02-Feb-2006 | Current |
Financial Performance of Spanker Biotech.
Spanker Biotech Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Spanker Biotech?
In 2023, Spanker Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pifer Pharmaceuticals Pvt LtdActive 30 years 9 monthsMunish Salwan and Mithun Salwan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 22 Oct 2021 | ₹1.40 Cr | Open |
Others Creation Date: 11 Aug 2021 | ₹2.20 M | Open |
State Bank Of India Creation Date: 04 Nov 2006 | ₹1.40 Cr | Open |
How Many Employees Work at Spanker Biotech?
Spanker Biotech has a workforce of 8 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spanker Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spanker Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.